Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 5(65), 2021
DOI: 10.1128/aac.02260-20
Links
Tools
Population Pharmacokinetics of Dalbavancin and Dosing Consideration for Optimal Treatment of Adult Patients with Staphylococcal Osteoarticular Infections
Journal article published in 2021 by
Pier Giorgio Cojutti,
Matteo Rinaldi 
,
Eleonora Zamparini,
Nicolò Rossi,
Sara Tedeschi,
Matteo Conti,
Federico Pea ,
Pierluigi Viale
,
Eleonora Zamparini,
Nicolò Rossi,
Sara Tedeschi,
Matteo Conti,
Federico Pea ,
Pierluigi Viale
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Dalbavancin is gaining interest in the treatment of complex osteoarticular (OA) infections. We aimed to conduct a population pharmacokinetic analysis of dalbavancin in a prospective cohort of adult patients with OA infections caused by Gram-positive organisms and to identify optimal dosing regimens for long-term treatment.